February 21, 2023
Surrozen Chooses TransPerfect’s Trial Interactive eClinical Platform for Comprehensive TMF Management
NEW YORK, FEBUARY 21, 2023 - TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced that Surrozen has selected its Trial Interactive eClinical platform, including electronic Trial Master File (eTMF) and TMF solutions to create a centralized, quality-focused approach to TMF management.